Stocks and Investing Stocks and Investing
Mon, March 25, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Vijay Bhagavath Downgraded (AKAM) to Strong Sell and Held Target at $58 on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Alex Kurtz Maintained (TWLO) at Buy with Increased Target to $150 on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Sheng Zhong Upgraded (TAL) to Buy on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Joseph Spak Reiterated (TSLA) at Sell with Decreased Target to $14 on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Daniel Kurnos Downgraded (TRUE) to Hold on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Ryan Zimmerman Upgraded (AXGN) to Strong Buy and Held Target at $28 on, Mar 25th, 2019
[ Mon, Mar 25th 2019 ] - WOPRAI
Stephen Byrd Initiated (VST) at Buy and Held Target at $35 on, Mar 25th, 2019
Fri, March 22, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Robert Simmons Initiated (SMAR) at Hold and Held Target at $45 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Christopher Tillett Initiated (WES) at Hold and Held Target at $34 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Danyal Hussain Maintained (WEX) at Hold with Increased Target to $197 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Matthew Brooklier Maintained (WAB) at Strong Buy with Decreased Target to $93 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Matthew Brooklier Downgraded (TRN) to Hold and Decreased Target to $26 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
James Hardiman Downgraded (BKNG) to Hold on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Nicholas Jansen Maintained (CDNA) at Strong Buy with Increased Target to $46 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Randal Konik Maintained (YETI) at Strong Buy with Increased Target to $40 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Dan Leonard Maintained (TMO) at Strong Buy with Increased Target to $300 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Matthew Niknam Maintained (UNIT) at Hold with Decreased Target to $8 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Derek Archila Initiated (AMRN) at Strong Buy and Held Target at $27 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Brian Nagel Upgraded (BBY) to Buy on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Matthew Harrison Downgraded (BIIB) to Sell on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Carter Gould Downgraded (BIIB) to Hold on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Robyn Karnauskas Downgraded (BIIB) to Hold and Decreased Target to $230 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Sumant Kulkarni Downgraded (BIIB) to Hold and Decreased Target to $275 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Salim Syed Downgraded (BIIB) to Hold and Decreased Target to $235 on, Mar 22nd, 2019
[ Fri, Mar 22nd 2019 ] - WOPRAI
Christopher Marai Maintained (BIIB) at Strong Buy with Decreased Target to $320 on, Mar 22nd, 2019
Thu, March 21, 2019
[ Thu, Mar 21st 2019 ] - WOPRAI
Laura Martin Upgraded (AAPL) to Strong Buy and Increased Target to $56 on, Mar 21st, 2019
[ Thu, Mar 21st 2019 ] - WOPRAI
Daniel Ives Maintained (AAPL) at Buy with Increased Target to $54 on, Mar 21st, 2019
[ Thu, Mar 21st 2019 ] - WOPRAI
Walter Pritchard Reiterated (AAPL) at Strong Buy with Increased Target to $55 on, Mar 21st, 2019
[ Thu, Mar 21st 2019 ] - WOPRAI
Bryan Keane Maintained (V) at Strong Buy with Increased Target to $177 on, Mar 21st, 2019
[ Thu, Mar 21st 2019 ] - WOPRAI
Charles Duncan Maintained (AXSM) at Buy with Increased Target to $25 on, Mar 21st, 2019

Charles Duncan Maintained (AXSM) at Buy with Increased Target to $25 on, Mar 21st, 2019


Published on 2024-10-26 12:43:06 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $16 to $25 on, Mar 21st, 2019.

Charles, nor any peers, have made any analyst calls on AXSM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources